Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » PerkinElmer Q1 Revenues Up 25 Percent

PerkinElmer Q1 Revenues Up 25 Percent

Apr 30, 2018
|
staff reporter

NEW YORK (GenomeWeb) – PerkinElmer reported after the close of the market on Monday that its first quarter revenues rose 25 percent year over year, thanks largely to a 62 percent increase in revenues from its diagnostics business.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Billion-Pound Sticking Point

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

Advisors Push for More Data

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

Moderna Expects Early Trial Data Next Month

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

Science Papers Explore Contribution of ANXA11 to ALS, Role of Gut Microbiome in Autism Spectrum Disorder

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.

What's Popular?

In Business News

  1. Helix Coronavirus Test FDA EUA Reissued to Include Specimen Self-Collection

  2. FDA Grants EUAs for Wren Labs, P23 Coronavirus Tests, Binx Health At-Home Sample Collection Kit

  3. New Products Posted to GenomeWeb: Qiagen, Fabric Genomics, Lexogen, More

  4. Invitae, Pacific Biosciences Collaborate on NGS-Based Pediatric Epilepsy Testing

  5. Sage Science to Distribute Universal Sequencing Technology's Sample Prep Kits in US

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.